Product Information
BUPRENORPHINE-NALOXONE 8-2 MG SL FILM is a generic product labeled by Alvogen Inc., priced at $1.9823 per EA under NDC 47781035703. Its NADAC has been published 390 times since Apr 17, 2019.
FDA first approved this application on Jan 24, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8; 2 mg/1; mg/1
Manufacturer
Alvogen Inc.NDC
47781035703
Classification
Generic
Dosage Form
FILM
Route
BUCCAL; SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205954FDA Approved
1/24/2019
TE Code
AB
On Market Since
2/11/2019
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM has been published 390 times since Apr 17, 2019, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9823 per EA |
|---|---|
| All-time high | $5.7260 (May 15, 2019) |
| All-time low | $1.6113 (Nov 20, 2024) |
| 52-week high | $2.0743 |
| 52-week low | $1.8801 |
| Median price | $3.2224 |
| Average price | $3.2696 |
| Largest weekly change | +28.0% (Dec 11, 2024) |
| Weeks tracked | 390 |
| Tracking since | Apr 17, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Buprenorphine and Naloxone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM, manufactured by Alvogen Inc., is $1.9823 per EA (NDC 47781035703), effective Sep 30, 2026.
How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL FILM changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM has declined 65.4%. It has been tracked across 390 weekly CMS publications since Apr 17, 2019.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
Since Apr 17, 2019, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM has ranged from a low of $1.6113 (Nov 20, 2024) to a high of $5.7260 (May 15, 2019), with a median of $3.2224 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 8-2 MG SL FILM in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
BUPRENORPHINE-NALOXONE 8-2 MG SL FILM (NDC 47781035703) is labeled by Alvogen Inc., and CMS classifies it as a generic product.